🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Brian Morrissey

Manchester Royal Infirmary

ORCID: 0000-0002-0137-7817

Also affiliated with Manchester University NHS Foundation Trust, Investigators Research Group (United States)

ChemistryMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials”.

Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00411-9
N/A
1.9DataRank · unranked
95 citations

Lael M. Yonker, F. Vermeulen, Dario Prais, Rachel W. Linnemann, Aaron Trimble +92 more

Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial

EClinicalMedicine(2023)10.1016/j.eclinm.2023.101889
N/A
0.787DataRank · unranked
35 citations

Neil R. Aggarwal, Timothy E. Albertson, Sara C. Auld, Jeremy R. Beitler, Paul Berger +86 more

Systematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial

Communications Medicine(2025)10.1038/s43856-025-01126-9
N/A
0DataRank · unranked
0 citations

Kathleen D. Liu, Derek W. Russell, D. Clark Files, Karl W. Thomas, Fady Yousef +86 more